India’s biotechnology firm Biocon Ltd expects its maiden venture to build a manufacturing and research & development (R&D) facility in Iskandar Malaysia, Johor, with an investment of more than RM500 million, to be operational by end-2014.
Its chairman and managing director Kiran Mazumdar-Shaw said the facility will be built in two phases, with an initial investment of RM250 million for the first phase which will start its production by early 2015.
“Once it starts, we will offer more than 250 skilled jobs,” she told reporters after signing a memorandum of understanding (MoU) between Biocon and Manipal Education Malaysia (MEM) in Petaling Jaya last Friday.
The ground-breaking ceremony for the first phase of development took place last year. The development for the second phase of the facilities will start in 2015 and is expected to be completed by 2020.
The MoU is for collaboration to develop human capital for the biotechnology industry in Malaysia. The agreement outlined the creation of an internship programme and graduate employment programme for the admission of Manipal International University’s students and graduates to Biocon’s Malaysia facility for training and employment.
“Universities cannot operate in isolation. Industry linkages are crucial to ensure continuous relevance between syllabus with industry development and latest R&D,” said MEM managing director/chief executive director Datuk Iskandar Mizal Mahmood.
“Industry linkages also provide our students with industrial training and employment opportunities, thus it is our aim to forge linkages with global industry leaders like Biocon.”